The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster
Open accessAbstract
VSMCs respond to changes in the local environment by adjusting their phenotype from contractile to synthetic, a phenomenon known as phenotypic modulation or switching. Failure of VSMCs to acquire and maintain the contractile phenotype plays a key role in a number of major human diseases, including arteriosclerosis. Although several regulatory circuits that control differentiation of SMCs have been identified, the decisive mechanisms that govern phenotypic modulation remain unknown. Here, we demonstrate that the mouse miR-143/145 cluster, expression of which is confined to SMCs during development, is required for VSMC acquisition of the contractile phenotype. VSMCs from miR-143/145-deficient mice were locked in the synthetic state, which incapacitated their contractile abilities and favored neointimal lesion development. Unbiased high-throughput, quantitative, mass spectrometry-based proteomics using reference mice labeled with stable isotopes allowed identification of miR-143/145 targets; these included angiotensin-converting enzyme (ACE), which might affect both the synthetic phenotype and contractile functions of VSMCs. Pharmacological inhibition of either ACE or the AT1 receptor partially reversed vascular dysfunction and normalized gene expression in miR-143/145-deficient mice. We conclude that manipulation of miR-143/145 expression may offer a new approach for influencing vascular repair and attenuating arteriosclerotic pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
miRBase: tools for microRNA genomics
Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,382
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796 · cited 2×
“The 3ʹ UTR and the ORF of mouse ACE contain several miR-145 binding sites with high scores and low energy as predicted by the miRanda algorithm (16) (Figure 5I).”
BackgroundMicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471
The microRNA.org resource: targets and expression
Betel, D., Wilson, M., Gabow, A., Marks, D. S., & Sander, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm995 · Cited by 2,503
Fabiato, A., & Fabiato, F. (1979) · PubMed · Cited by 1,631
Ross, R., & Glomset, J. A. (1973) · Science · doi:10.1126/science.180.4093.1332 · Cited by 1,501
The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution
Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
“However, contractility of the blood vessels of these mice is compromised, suggesting a subtle shift toward a less differentiated phenotype (Boettger et al., 2009).”
BackgroundAtheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,305
Self-citationCirculating MicroRNAs in Patients With Coronary Artery Disease
Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C. W., Röxe, T., Müller-Ardogan, M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215566 · Cited by 1,233
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Linking actin dynamics and gene transcription to drive cellular motile functions
Olson, E. N., & Nordheim, A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2890 · Cited by 958
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment
Klattenhoff, C. A., Scheuermann, J. C., Surface, L. E., Bradley, R. K., Fields, P. A., Steinhauser, M. L., Ding, H., Butty, V. L., Torrey, L., Haas, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.003 · Cited by 913
Vascular smooth muscle contraction in hypertension
Touyz, R. M., Alves-Lopes, R., Rios, F. J., Camargo, L. L., Anagnostopoulou, A., Arner, A., & Montezano, A. C. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy023 · Cited by 697
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 624
MicroRNAs Add a New Dimension to Cardiovascular Disease
Small, E. M., Frost, R. J. A., & Olson, E. N. (2010) · Circulation · doi:10.1161/circulationaha.109.889048 · Cited by 599
Brozovich, F. V., Nicholson, C. J., Degen, C. V., Gao, Y. Z., Aggarwal, M., & Morgan, K. G. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010652 · Cited by 542
Resistin: functional roles and therapeutic considerations for cardiovascular disease
Jamaluddin, M. S., Weakley, S. M., Yao, Q., & Chen, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01369.x · Cited by 536
van Rooij, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.227496 · Cited by 534
Jordan, S. D., Krüger, M., Willmes, D. M., Redemann, N., Wunderlich, F. T., Brönneke, H. S., Merkwirth, C., Kashkar, H., Olkkonen, V. M., Böttger, T., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2211 · Cited by 520
Self-citationVascular smooth muscle cells in atherosclerosis: time for a re-assessment
Grootaert, M. O. J., & Bennett, M. R. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab046 · Cited by 509
MicroRNA Regulatory Networks in Cardiovascular Development
Liu, N., & Olson, E. N. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.010 · Cited by 491
MicroRNAs in cardiovascular disease: an introduction for clinicians
Romaine, S. P. R., Tomaszewski, M., Condorelli, G., & Samani, N. J. (2015) · Heart · doi:10.1136/heartjnl-2013-305402 · Cited by 476
Regulation of gastrointestinal motility—insights from smooth muscle biology
Sanders, K. M., Koh, S. D., Ro, S., & Ward, S. M. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.168 · Cited by 452
The Role of miRNAs in Regulating Gene Expression Networks
Gurtan, A. M., & Sharp, P. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.007 · Cited by 443
Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity
Frismantiene, A., Philippova, M., Erne, P., & Resink, T. J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.08.019 · Cited by 406
microRNAs in Cardiovascular Diseases
Condorelli, G., Latronico, M. V. G., & Cavarretta, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.050 · Cited by 375
Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling
Kubin, T., Pöling, J., Kostin, S., Gajawada, P., Hein, S., Rees, W., Wietelmann, A., Tanaka, M., Lörchner, H., Schimanski, S., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.08.013 · Cited by 359
Self-citationVascular Smooth Muscle Cell Proliferation in Restenosis
Marx, S. O., Totary-Jain, H., & Marks, A. R. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.110.957332 · Cited by 354
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 334
Davies, P. F., Civelek, M., Fang, Y., & Fleming, I. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt101 · Cited by 331
Roncarati, R., Viviani Anselmi, C., Losi, M. A., Papa, L., Cavarretta, E., Da Costa Martins, P., Contaldi, C., Saccani Jotti, G., Franzone, A., Galastri, L., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.041 · Cited by 327
Characterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs
Wagner, J., Riwanto, M., Besler, C., Knau, A., Fichtlscherer, S., Röxe, T., Zeiher, A. M., Landmesser, U., & Dimmeler, S. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300741 · Cited by 325
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 300
Torella, D., Iaconetti, C., Catalucci, D., Ellison, G. M., Leone, A., Waring, C. D., Bochicchio, A., Vicinanza, C., Aquila, I., Curcio, A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.240150 · Cited by 293
Deng, L., Blanco, F. J., Stevens, H., Lu, R., Caudrillier, A., McBride, M., McClure, J. D., Grant, J., Thomas, M., Frid, M., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306806 · Cited by 292
Scioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281
“Some studies demonstrated that VEGF signaling is modified in SAH.”
BackgroundInfluentialMicroRNA-145 Targeted Therapy Reduces Atherosclerosis
Lovren, F., Pan, Y., Quan, A., Singh, K. K., Shukla, P. C., Gupta, N., Steer, B. M., Ingram, A. J., Gupta, M., Al-Omran, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.084186 · Cited by 281
MicroRNA‐26a is a novel regulator of vascular smooth muscle cell function
Leeper, N. J., Raiesdana, A., Kojima, Y., Chun, H. J., Azuma, J., Maegdefessel, L., Kundu, R. K., Quertermous, T., Tsao, P. S., & Spin, J. M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22422 · Cited by 280
Caruso, P., Dempsie, Y., Stevens, H. C., McDonald, R. A., Long, L., Lu, R., White, K., Mair, K. M., McClure, J. D., Southwood, M., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.267591 · Cited by 278
MicroRNA-145 Regulates Chondrogenic Differentiation of Mesenchymal Stem Cells by Targeting Sox9
Yang, B., Guo, H., Zhang, Y., Chen, L., Ying, D., & Dong, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021679 · Cited by 268
Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells
Leung, A., Trac, C., Jin, W., Lanting, L., Akbany, A., Sætrom, P., Schones, D. E., & Natarajan, R. (2013) · Circulation Research · doi:10.1161/circresaha.112.300849 · Cited by 268
Fernandes, T., Hashimoto, N. Y., Magalhães, F. C., Fernandes, F. B., Casarini, D. E., Carmona, A. K., Krieger, J. E., Phillips, M. I., & Oliveira, E. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168252 · Cited by 253
MicroRNAs Are Necessary for Vascular Smooth Muscle Growth, Differentiation, and Function
Albinsson, S., Suarez, Y., Skoura, A., Offermanns, S., Miano, J. M., & Sessa, W. C. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.200873 · Cited by 253
MicroRNA therapeutics in cardiovascular medicine
Thum, T. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100191 · Cited by 193
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity
Guerau-de-Arellano, M., Smith, K. M., Godlewski, J., Liu, Y., Winger, R., Lawler, S. E., Whitacre, C. C., Racke, M. K., & Lovett-Racke, A. E. (2011) · Brain · doi:10.1093/brain/awr262 · Cited by 188
Bhaskaran, V., Nowicki, M. O., Idriss, M., Jimenez, M. A., Lugli, G., Hayes, J. L., Mahmoud, A. B., Zane, R. E., Passaro, C., Ligon, K. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08390-z · Cited by 105
Rodríguez, A. I., Csányi, G., Ranayhossaini, D. J., Feck, D. M., Blose, K. J., Assatourian, L., Vorp, D. A., & Pagano, P. J. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304936 · Cited by 100
Atheroprotective mechanisms of shear stress-regulated microRNAs
Boon, R. A., Hergenreider, E., & Dimmeler, S. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0491 · Cited by 78
Lin, L., Hou, J., Ma, F., Wang, P., Liu, X., Li, N., Wang, J., Wang, Q., & Cao, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203450 · Cited by 73
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
“miR-143 and miR-145 are transcribed from the same cluster and play a critical role in smooth muscle differentiation (115).”
Background
Metadata
- Authors
- Boettger, T., Beetz, N., Kostin, S., Schneider, J., Krüger, M., Hein, L., & Braun, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-09-01
- Volume
- 119
- Issue
- 9
- Pages
- 2634-2647
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2018621592
- Cited by
- 651
- References
- 51
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.